COMMITTEE ON AGING (Senate, Special)

Bills and resolutions

Expenditures: authorizing (see S. Res. 25)

Hearings

Board and care facilities for elderly: (testimony), D103 [9MR]

Effects of drug abuse on the elderly in urban and rural areas: (testimony), D769 [15NO]

Nursing home reform: (testimony), D290 [18MY]

Prescription drug manufacturer pricing and policy and their impact on medicaid: (testimony), D777 [16NO]

Prescription drug prices: (testimony), D436 [18JY]

Safeguards to protect the rights of beneficiaries of the Social Security representative payee system: (testimony), D321 [6JN]

Social Security Administration's toll-free telephone system and the quality of its service: (testimony), D168 [10AP]

Meetings

Funding, D53 [23FE]

Organization, operating expenses and rules of procedure, D16 [27JA]

Papers

Prescription Drug Prices—Are We Getting Our Money's Worth?, 16839 [31JY]

Remarks in Senate

Meetings: during sessions, 3984 [9MR], 9930 [18MY], 11004 [6JN], 15066 [18JY], 22170 [27SE], 29418 [16NO]

Notices of hearings, 2472 [22FE], 3159 [1MR], 5424 [4AP], 8579 [9MY], 10374 [31MY], 18020 [2AU], 21445 [25SE], 22575 [29SE], 27147 [3NO], 27676 [7NO], 28717 [14NO], 29234 [15NO]

Reports filed

Authorizing Expenditures (S. Res. 25), 1241 [31JA]

Rules

Procedure, 4662 [16MR]

Texts of

S. Res. 25, authorizing expenditures, 1327 [31JA]